Low and high dose UVB regulation of transcription factor NF-E2-related factor 2

Cancer Research

Volumn 66, Issue 17, 2006, Pages 8421-8429

  Kannan, Sankaranarayanan ^a,b   Jaiswal, Anil K ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; LEPTOMYCIN B; PHENYLALANINE; PROTEIN KINASE FYN; TRANSCRIPTION FACTOR NRF2;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KERATINOCYTE; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; RNA INTERFERENCE; SKIN FIBROBLAST; ULTRAVIOLET B RADIATION; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; DNA PRIMERS; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; KERATINOCYTES; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; MICE; NF-E2-RELATED FACTOR 2; POLYMERASE CHAIN REACTION; SKIN; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 33749029694     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-1181     Document Type: Article

References (46)

1. Ross D, Kepa JK, Winski SL, et al. NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphism. Chem Biol Interact 2000;129:77-97.
2. Long DJ II, Jaiswal AK. NRH:quinone oxidoreductase 2 (NQO2). Chem Biol Interact 2000;129:99-112.
3. Radjendirane V, Joseph P, Lee H, et al. Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity. J Biol Chem 1998;273:7382-9.
4. Long DJ, Iskander K, Gaikwad A, et al. Disruption of dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2) leads to myeloid hyperplasia of bone marrow and decreased sensitivity to menadione toxicity. J Biol Chem 2002;277:46131-9.
5. Long DJ II, Gaikwad A, Multani A, et al. Disruption of the NAD(P)H:quinone oxidoreductase 1 (NQO1) gene in mice causes myelogenous hyperplasia. Cancer Res 2002;62:3030-6.
6. LongII DJ, Waikel RL, Wang X et al. NAD(P)H:quinone oxidoreductase 1 (NQO1) deficiency increases susceptibility to 7, 12-dimethylbenz[a]anthracene induced mouse skin carcinogenesis. J Natl Cancer Inst 2001;93:1166-70.
7. Iskander K, Paquet M, Brayton C, et al. Deficiency of NRH:quinone oxidoreductase 2 (NQO2) increases susceptibility to 7,12-Dimethylbenz[a] anthracene and benzo(a)pyrene-induced skin carcinogenesis. Cancer Res 2004;64:5923-8.
8. Rothman N, Smith MT, Hayes RB, et al. Benzene poisoning, a risk factor for hematologic malignancy, is associated with NQO1 609 C → T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res 1997;57:2839-42.
9. Larson RA, Wang Y, Banerjee M, et al. Prevalence of the inactivating 609C → T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. Blood 1999;94:803-7.
10. Park SJ, Zhao H, Spitz MR, et al. An association between NQO1 genetic polymorphism and risk of bladder cancer. Mutat Res 2003;536:131-7.
11. Menzel HJ, Sarmanova J, Soucek P, et al. Association of NQO1 polymorphism with spontaneous breast cancer in two independent populations. Br J Cancer 2004;90:1989-94.
12. Sarbia M, Bitzer M, Siegel D, et al. Association between NAD(P)H:quinone oxidoreductase 1 (NQO1) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract. Int J Cancer 2003;107: 381-6.
13. Jaiswal AK. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic Biol Med 2004;36:1199-207.
14. Chan K, Lu R, Chang JC, et al. Nrf2, a member of the NF-E2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc Natl Acad Sci U S A 1996;93:13943-8.
15. Dhakshinamoorthy S, Jaiswal AK. Functional characterization and role of INrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene. Oncogene 2001;20:3906-17.
16. Itoh K, Wakabayashi N, Katoh Y, et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 1999;13:76-86.
17. Nguyen T, Sherratt PJ, Huang HC, et al. Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element-degradation of Nrf2 by the 26S proteasome. J Biol Chem 2003;278:4536-41.
18. Sekhar KR, Yan XX, Freeman ML. Nrf2 degradation by the ubiquitin proteasome pathway is inhibited by KIAA0132, the human homolog to INrf2. Oncogene 2002;21:6829-34.
19. Bloom DA, Jaiswal AK. Phosphorylation of Nrf2 at Ser(40) by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression. J Biol Chem 2003;278:44675-82.
20. Wakabayashi N, Itoh K, Wakabayashi J, et al. Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat Genet 2003;35:238-45.
21. Yu R, Chen C, Mo YY, et al. Activation of mitogen-activated protein kinase pathways induces antioxidant response element-mediated gene expression via a Nrf2-dependent mechanism. J Biol Chem 2000;275:39907-13.
22. Alam J, Wicks C, Stewart D, et al. Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells. Role of p38 kinase and Nrf2 transcription factor. J Biol Chem 2000;275:27694-702.
23. Huang HC, Nguyen T, Pickett CB. Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2. Proc Natl Acad Sci U S A 2000;97:12475-80.
24. Zipper LM, Mulcahy RT. Inhibition of ERK and p38 MAP kinases inhibits binding of Nrf2 and induction of GCS genes. Biochem Biophys Res Commun 2000;278:484-92.
25. Lee JM, Hanson JM, Chu WA, et al. Phosphatidylinositol 3-kinase, not extracellular signal-regulated kinase, regulates activation of the antioxidant-responsive element in IMR-32 human neuroblastoma cells. J Biol Chem 2001;276:20011-6.
26. Kong AN, Owuer E, Yu R, et al. Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE/ EpRE). Drug Metab Rev 2001;33:255-71.
27. Huang HC, Nguyen T, Pickett CB. Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J Biol Chem 2002;277:42769-74.
28. Kang KW, Cho IJ, Lee CH, et al. Essential role of phosphatidylinositol 3-kinase-dependent CCAAT/enhancer binding protein β activation in the induction of glutathione S-transferase by oltipraz. J Natl Cancer Inst 2003;95:53-66.
29. Zipper LM, Mulcahy RT. Erk activation is required for Nrf2 nuclear localization during pyrrolidine dithiocarbamate induction of glutamate cysteine ligase modulatory gene expression in Hep-G2 cells. Toxicol Sci 2003;73:124-34.
30. Numazawa S, Ishikawa M, Yoshida A, et al. Atypical protein kinase C mediates activation of NF-E2-related factor 2 in response to oxidative stress. Am J Physiol Cell Physiol 2003;285:C334-42.
31. Levonen AL, Landar A, Ramachandran A, et al. Cellular mechanisms of redox cell signaling: the role of cysteine modification in controlling antioxidant defenses in response to electrophilic lipid oxidation products. Biochem J 2004;378:373-82.
32. Velichkova M, Hasson T. Keap1 regulates the oxidation-sensitive shuttling of Nrf2 into and out of the nucleus via a Crm1-dependent nuclear export mechanism. Mol Cell Biol 2005;25:4501-13.
33. Karapetian RN, Evstafieva AG, Abaeva IS, et al. Nuclear oncoprotein prothymosin α is a partner of Keap1: implications for expression of oxidative stress-protecting genes. Mol Cell Biol 2005;25:1089-99.
34. Jain AK, Jaiswal AK. Nuclear import and export signals in control of Nrf2. J Biol Chem 2005;380:29158-68.
35. Ramos J, Villa J, Ruiz A, et al. UV dose determines key characteristics of nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev 2004;13:2006-11.
36. Gao X, Talalay P. Induction of phase 2 genes by sulforaphane protects retinal pigment epithelial cells against photooxidative damage. Proc Natl Acad Sci U S A 2004;101:10446-51.
37. Dhakshinamoorthy S, Jaiswal AK. Small Maf (MafG and MafK) proteins negatively regulate antioxidant response element-mediated expression and antioxidant induction of the NAD(P)H:quinone oxidoreductase 1 gene. J Biol Chem 2000;275:40134-41.
38. Sankaranarayanan K, Jaiswal AK. Nrf3 negatively regulates antioxidant-response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase 1 gene. J Biol Chem 2004;279:50810-7.
39. Ducret C, Maira SM, Dierich A, et al. The net repressor is regulated by nuclear export in response to anisomycin, UV, and heat shock. Mol Cell Biol 1999;19:7076-87.
40. Haendeler J, Hoffmann J, Brandes RP, et al. Hydrogen peroxide triggers nuclear export of telomerase reverse transcriptase via Src kinase family-dependent phosphorylation of tyrosine 707. Mol Cell Biol 2003;23:4598-610.
41. He Z, Cho YY, Ma WY, et al. Regulation of ultraviolet B-induced phosphorylation of histone H3 at serine 10 by Fyn kinase. J Biol Chem 2005;280:2446-54.
42. Parsons S, Parsons JT. Src family kinases, key regulators of signal transduction. Oncogene 2004;23:7906-9.
43. Hirota A, Kawachi Y, Itoh K, et al. Ultraviolet A irradiation induces NF-E2 related factor 2 activation in dermal fibroblasts: protective role in UVA-induced apoptosis. J Invest Dermatol 2005;124:825-32.
44. Sano S, Chan KS, Kira M, et al. Signal transducer and activator of transcription 3 is a key regulator of keratinocyte survival and proliferation following UV irradiation. Cancer Res 2005;65:5720-9.
45. Brash DE, Ziegler A, Jonason AS, et al. Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J Investig Dermatol Symp Proc 1006;1:136-42.
46. Kraemer KH. Sunlight and skin cancer: another link revealed. Proc Natl Sci Acad U S A 1997;94:11-4.